Open AccessMetastatic Mediastinal Germ‐Cell Tumor and Concurrent COVID ‐19: When Chemotherapy Is Not Deferrable
Author(s) -
Pedrazzoli Paolo,
Rondonotti David,
Cattrini Carlo,
Secondino Simona,
Ravanini Paolo,
Piralla Antonio,
Sainaghi Pier Paolo,
Brustia Diego,
Bozzola Cristina,
Gariglio Marisa,
Cossandi Christian,
Rosti Giovanni,
Gennari Alessandra
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13647
Subject(s) - chemotherapy , covid-19 , germ cell tumors , medicine , germ cell , oncology , cancer research , virology , biology , disease , outbreak , infectious disease (medical specialty) , gene , biochemistry
This letter to the editor describes the case of a patient with mediastinal germ cell tumor who developed COVID‐19 at the end of the first cycle of chemotherapy and continues the discussion on whether it is best to continue or delay administration of chemotherapy with an active COVID‐19 infection.